Skip to content

Ayahuasca research published in 2021

Page 3 of 4: studies 41 to 60 of 67, newest first. Back to the ayahuasca overview

Studies

Ayahuasca-Tourismus in Peru: Motivationen und subjektive Bedeutungen bei Teilnehmern von Ayahuasca-Retreats im oberen Amazonasgebiet

Zeitschrift für Tourismuswissenschaft April 27, 2021 Tom Wolff

Zusammenfassung Ayahuasca ist ein stark psychoaktiver Trank des Amazonas-Regenwaldes, der zu einem florierenden Tourismus aus den industrialisierten Ländern ins ländliche Peru geführt hat. In einer teilnehmenden Beobachtung und qualitativen Befragung von Teilnehmern von traditionalisierten Ayahuasca-Seminaren im Regenwald werden Motive und subjektive Bedeutungen mittels qualitativer...

Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International Survey.

Frontiers in Pharmacology April 21, 2021 Daniel Perkins, Violeta Schubert, Hana Šimonová et al. 73 citations

Ayahuasca is a traditional plant decoction containing N,N-dimethyltryptamine (DMT) and various β-carbolines including harmine, harmaline, and tetrahydroharmine, which has been used ceremonially by Amazonian Indigenous groups for healing and spiritual purposes. Use of the brew has now spread far beyond its original context of consumption to North America, Europe, and Australia in neo-shamanic...

DOI: 10.3389/fphar.2021.623979 (opens in new tab) Full text (opens in new tab) Ayahuasca context Ayahuasca setting Ayahuasca environment Ayahuasca preparation +16

Symptom specificity of ayahuasca's effect on depressive symptoms

Journal of Psychedelic Studies April 19, 2021 Cody Gilbert, Mitch Earleywine, Maha N. Mian et al. 3 citations

Abstract Background Ayahuasca's effects on symptoms of depression have generated considerable optimism. Clients frequently report more concern about some symptoms than others, and available treatments alter symptoms differentially. Few studies address the symptom specificity of this psychoactive brew. Aims We examined self-reported effects of ayahuasca on the individual symptoms of depression...

Back to the Future — The Therapeutic Potential of Psychedelic Drugs

New England Journal of Medicine April 14, 2021 Jeffrey A. Lieberman 18 citations

In The Doors of Perception, Aldous Huxley described his trial of mescaline as "the most extraordinary and significant experience available to human beings this side of the Beatific Vision." His exegesis was preceded by the synthesis of the hallucinogen lysergic acid diethylamide (LSD) by Sandoz chemist Albert Hoffman in 1938 and was followed by Hoffman's extraction of psilocybin from Psilocybe...

Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers

Journal of Clinical Psychopharmacology April 13, 2021 Juliana Mendes Rocha, Giordano Novak Rossi, Flávia de Lima Osório et al. 46 citations

Abstract Background The recognition of emotions in facial expressions (REFE) is a core aspect of social cognition. Previous studies with the serotonergic hallucinogens lysergic acid diethylamide and psilocybin showed that these drugs reduced the recognition of negative (fear) faces in healthy volunteers. This trial assessed the acute and prolonged effects of a single dose of ayahuasca on the...

Altered vision: Ayahuasca shamanism and sensory individualism

Current Anthropology April 1, 2021 Alex K. Gearin, Óscar Calavia Sáez 15 citations

Notions of visualism and individualism have long been employed to elucidate the contours of Western subjectivity. It is therefore not surprising to find the indigenous Amazonian shamanic brew ayahuasca being adopted by Australian neoshamanic practitioners as a medicine that provides personalized visions delivering unambiguous moral import. While this adoption represents a radically new style of...

Ayahuasca potential benefits

European Psychiatry April 1, 2021 R. Pinilla, Carmen Rocamora Rodriguez, D. Batet-Sanchez et al. 3 citations

Introduction Ayahusca has potential therapeutic beneffits. Objectives Expose the potential beneffits of ayahuasca from neuropharmacology and clinical existing evidence. Methods A literature review was carried out in the databases pubmed, clinical key and texts of scientific dissemination. Results There´s scientific literature about the potential therapeutic use of ayahuasca in dependencies,...

Psychedelics: A new era of treatment?

European Psychiatry April 1, 2021 S. Torres 2 citations

Introduction Psychedelics - including LSD (lysergic acid diethylamide), psilocybin, DMT (N, N-dimethyltryptamine), ayahuasca and mescaline - have an ancient history across various civilizations. In 1950, after LSD’s discovery by Hofmann, psychedelics enjoyed a short-lived relationship with psychiatry, before prohibitive legislature emerging in response to the recreational use in the mid-1960s....

A Qualitative Study of Intention and Impact of Ayahuasca Use by Westerners

April 1, 2021 Geoff J. Bathje, Jon Fenton, Daniel Pillersdorf et al. 23 citations preprint

Ayahuasca has gained the attention of researchers over the past decade as psychedelic-assisted therapy for MDMA and psilocybin have progressed through FDA approved clinical trials. In spite of the increase in research, there are relatively few clinical studies of ayahuasca and little qualitative research on the therapeutic or healing uses of psychedelics in general. The present study included...

Examining changes in personality following shamanic ceremonial use of ayahuasca.

Scientific Reports March 23, 2021 Brandon Weiss, Joshua D. Miller, Nathan T. Carter et al. 80 citations

Abstract The present study examines the association between the ceremonial use of ayahuasca—a decoction combining the Banistereopsis caapi vine and N,N-Dimethyltryptamine-containing plants—and changes in personality traits as conceived by the Five-Factor model (FFM). We also examine the degree to which demographic characteristics, baseline personality, and acute post-ayahuasca experiences...

Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action

Journal of Psychopharmacology March 19, 2021 Rafael G. Dos Santos, Jaime Ec Hallak, Glen B. Baker et al. 51 citations

Major depressive disorder (MDD) is among the most prevalent mental health disorders worldwide, and it is associated with a reduced quality of life and enormous costs to health care systems. Available drug treatments show low-to-moderate response in most patients, with almost a third of patients being non-responders (treatment-resistant). Furthermore, most currently available medications need...

A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats

Psychopharmacology March 10, 2021 Malin V. Uthaug, Natasha L. Mason, Stefan W. Toennes et al. 116 citations

Abstract Ayahuasca is a plant concoction containing N,N -dimethyltryptamine (DMT) and certain β-carboline alkaloids from South America. Previous research in naturalistic settings has suggested that ingestion of ayahuasca can improve mental health and well-being; however, these studies were not placebo controlled and did not control for the possibility of expectation bias. This naturalistic...

Potential Risks of Plant Constituents in Dietary Supplements: Qualitative and Quantitative Analysis of Peganum harmala Seeds

Molecules March 4, 2021 Matilde Calderoni, Maddalena Altare, Luca Mastracci et al. 8 citations

The free online trading of herbal mixtures useful for various purposes facilitates the circulation of dangerous herbs or plant parts. This is the case, for example, of the illegal trade in seeds of Peganum harmala (Pgh), which contain alkaloids capable of inhibiting monoamine oxidase (MAO) and are therefore used in hallucinogenic preparations, such as the psychedelic drink ayahuasca. The...

DOI: 10.3390/molecules26051368 (opens in new tab) Ayahuasca Peganum harmala Identification biology Traditional medicine +2

The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges

Risk Management and Healthcare Policy March 1, 2021 Rafael G. Dos Santos, José Carlos Bouso, Juliana Mendes Rocha et al. 58 citations

Psychedelics or serotonergic hallucinogens are a group of substances that share the agonism of serotonergic 5-HT2A receptors as their main mechanism of action. Its main effects include changes in perception, cognitive process, and mood. Despite being used for centuries by different cultures in ritual contexts, these substances have currently aroused the interest of science and industry for...

Accidental Environmentalism: Nature and Cultivated Affect in European Neoshamanic Ayahuasca Consumption

Anthropology of Consciousness February 12, 2021 Arne Harms 7 citations

Abstract Existing research demonstrates a positive connection between psychedelics and increased nature relatedness. Enhanced affective ties toward nature are widely framed as being built into the pharmakon itself, and the relevance of experiences remains little understood. This paper turns to neoshamanic ayahuasca ceremonies in Europe, exploring the way specialists and attendants refer to...

DOI: 10.1111/anoc.12130 (opens in new tab) Ayahuasca Environmentalism Curiosity Affect linguistics +8

Ayahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers

Journal of Affective Disorders Reports February 6, 2021 Jerome Sarris, Daniel Perkins, Lachlan Cribb et al. 72 citations

Background\nAyahuasca is a psychoactive Amazonian brew which has emerging data indicating that it has antidepressant and anxiolytic properties.\n\nMethods\nThis paper uses data from the Global Ayahuasca Project (GAP), which was undertaken across 2017-2020 and involved 11912 people, to examine the perceived effects of ayahuasca consumption on affective symptoms. The study focused on the...

DOI: 10.1016/j.jadr.2021.100098 (opens in new tab) Ayahuasca Anxiety Depression economics Clinical psychology +2

Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial.

Psychopharmacology February 1, 2021 Richard J. Zeifman, Nikhita Singhal, Rafael G. Dos Santos et al. 79 citations

Suicidality is a major public health concern with limited treatment options. Accordingly, there is a need for innovative interventions for suicidality. Preliminary evidence indicates that treatment with the psychedelic ayahuasca may lead to decreases in depressive symptoms among individuals with major depressive disorder (MDD). However, there remains limited understanding of whether ayahuasca...

Experimentações enteogênicas: Santa Maria e Exu no Santo Daime

January 15, 2021 Jessica Rocha

This is a cartographic record that suggests ways to envisage the formation and expansion of the Santo Daime doctrine. From the daimist liturgy and the institutionalized practices in the Santo Daime / ICEFLU, also from their dissent, the narrative mapping the Marian subjectivities to ritualize the use of Marijuana was mapped, and how relations with Exu are conceived and ritualized. We pay...

Traditional Use of Banisteriopsis caapi Alone and Its Application in a Context of Drug Addiction Therapy.

Journal of Psychoactive Drugs 2021 Matteo Politi, Fabio Friso, Gary Saucedo et al. 18 citations

Takiwasi is a therapeutic community for the treatment of Substance Use Disorders (SUDs) that combines traditional Amazonian medicine (TAM) with modern psychotherapy. One of the plant medicines from TAM used in this protocol is purgahuasca. It is a decoction of the vine Banisteriopsis caapi alone, whose use is traditional among the Awajún and other ethnic groups in Peru. The research began with...